Amwill Health Care Limited (BOM:544353)
India
· Delayed Price · Currency is INR 79.11
-3.76 (-4.54%)
At close: May 9, 2025
Amwill Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2018 - 2019 |
| Revenue | 439.48 | 301.66 | 276.13 | 179.99 | 1.43 | Upgrade
|
| Revenue Growth (YoY) | 45.69% | 9.25% | 53.41% | 12465.18% | - | Upgrade
|
| Cost of Revenue | 120.69 | 90.68 | 87.71 | 80.3 | 0.83 | Upgrade
|
| Gross Profit | 318.79 | 210.98 | 188.43 | 99.7 | 0.6 | Upgrade
|
| Selling, General & Admin | 94.22 | 104.82 | 86.93 | 70.42 | 1.64 | Upgrade
|
| Other Operating Expenses | 57.9 | 62.74 | 64.02 | 39.52 | 0.1 | Upgrade
|
| Operating Expenses | 154.51 | 170.4 | 154.22 | 110.01 | 1.74 | Upgrade
|
| Operating Income | 164.28 | 40.58 | 34.2 | -10.31 | -1.13 | Upgrade
|
| Interest & Investment Income | 3.08 | 1.16 | 0.02 | - | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0 | -0.04 | Upgrade
|
| EBT Excluding Unusual Items | 167.36 | 41.74 | 34.22 | -10.31 | -1.17 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.28 | - | -0.88 | - | - | Upgrade
|
| Pretax Income | 167.64 | 41.74 | 33.35 | -10.31 | -1.17 | Upgrade
|
| Income Tax Expense | 42.64 | 10.6 | 7.61 | -0.33 | -0 | Upgrade
|
| Net Income | 125 | 31.14 | 25.74 | -9.98 | -1.17 | Upgrade
|
| Net Income to Common | 125 | 31.14 | 25.74 | -9.98 | -1.17 | Upgrade
|
| Net Income Growth | 301.36% | 21.01% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 0 | Upgrade
|
| Shares Change (YoY) | 0.02% | - | - | 51887.16% | 0.00% | Upgrade
|
| EPS (Basic) | 8.01 | 2.00 | 1.65 | -0.64 | -39.02 | Upgrade
|
| EPS (Diluted) | 8.01 | 2.00 | 1.65 | -0.64 | -39.02 | Upgrade
|
| EPS Growth | 301.27% | 21.02% | - | - | - | Upgrade
|
| Free Cash Flow | -39.47 | 44.77 | 29.07 | -7.32 | - | Upgrade
|
| Free Cash Flow Per Share | -2.53 | 2.87 | 1.86 | -0.47 | - | Upgrade
|
| Gross Margin | 72.54% | 69.94% | 68.24% | 55.39% | 42.13% | Upgrade
|
| Operating Margin | 37.38% | 13.45% | 12.39% | -5.73% | -79.01% | Upgrade
|
| Profit Margin | 28.44% | 10.32% | 9.32% | -5.54% | -81.72% | Upgrade
|
| Free Cash Flow Margin | -8.98% | 14.84% | 10.53% | -4.07% | - | Upgrade
|
| EBITDA | 166.62 | 42.89 | 37.46 | -10.25 | -1.13 | Upgrade
|
| EBITDA Margin | 37.91% | 14.22% | 13.56% | -5.69% | -78.98% | Upgrade
|
| D&A For EBITDA | 2.33 | 2.31 | 3.25 | 0.07 | 0 | Upgrade
|
| EBIT | 164.28 | 40.58 | 34.2 | -10.31 | -1.13 | Upgrade
|
| EBIT Margin | 37.38% | 13.45% | 12.39% | -5.73% | -79.01% | Upgrade
|
| Effective Tax Rate | 25.44% | 25.39% | 22.82% | - | - | Upgrade
|
| Revenue as Reported | 442.84 | 302.83 | 276.15 | 179.99 | 1.43 | Upgrade
|
| Advertising Expenses | 37.68 | 29.33 | 22.34 | 31.64 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.